William "Obi" Greenman transitioned from President and Chief Executive Officer to Executive Chairman of the Board effective July 1, 2026. Under the amended employment agreement, he will receive an annual base salary of $500,000 and a 2026 target cash bonus opportunity of 80% of his base salary. Cerus Corporation is a biotechnology company that develops and manufactures blood safety technologies.
